The life sciences industry has faced significant shifts in financing, dealmaking and investment. But what comes next?
Is the market experiencing a reset, a rebound or a more fundamental regime change?
In this on-demand Clarivate webinar, industry experts examine the forces shaping the current life sciences landscape and what they could mean for the future of biotech financing and dealmaking.